Yi Ding
机构：Sun Yat-sen University, Huazhong Agricultural University, Southwest Medical University, Soochow University, Affiliated Hospital of Southwest Medical University, Nanfang Hospital, The First People's Hospital of Changzhou, Chinese Academy of Forestry, State Forestry and Grassland Administration, Second Affiliated Hospital of Jilin University, Third Affiliated Hospital of Sun Yat-sen University, First Affiliated Hospital of Soochow University, Institute of Forest Ecology, Environment and Protection, Changzhou Third People's Hospital, Southern Medical University · ORCID：0000-0003-3968-8490
发表论文 123 篇 · 总被引 2162 次 · h-index 26
代表论文
- 653O Glecirasib (KRAS G12C inhibitor) in combination with JAB-3312 (SHP2 inhibitor) in patients with KRAS p.G12C mutated solid tumors (2023 · Annals of Oncology · 被引 27)
- A large study of metabolomics reveals common and distinct metabolic biomarkers for type 2 diabetes, coronary heart disease, and stroke (2024 · American Journal of Epidemiology · 被引 16)
- EPAC inhibitor suppresses angiogenesis and tumor growth of triple-negative breast cancer (2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 被引 9)
- Electroacupuncture Relieves Neuropathic Pain via Adenosine 3 Receptor Activation in the Spinal Cord Dorsal Horn of Mice (2024 · International Journal of Molecular Sciences · 被引 8)
- Total neoadjuvant therapy integrating long-course radiotherapy with trifluridine/tipiracil for locally advanced rectal cancer: a single-arm, multicenter phase 2 trial (2025 · EClinicalMedicine · 被引 5)
- Post-marketing safety concerns with Tislelizumab: a disproportionality analysis of the FDA adverse event reporting system (2025 · Frontiers in Immunology · 被引 5)